Related Experiment Video
Updated: Jul 12, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Treatment of hemiplegic migraine with triptans
V Artto1, M Nissilä, M Wessman
1Department of Neurology, Helsinki University Central Hospital, Finland. ville.artto@hus.fi
Abstract:
The objective of this study was to investigate the efficacy, safety and tolerability of triptans in patients who suffer from familial or sporadic hemiplegic migraine. Seventy-six subjects had used triptans at least once as an abortive treatment. Average triptan response was 6.9 (SD +/-3.1) and adverse event severity 4.9 (SD +/-3.3) on a scale from 0 to 10 (no response or side effect 0, excellent response or unbearable side effects 10). None of the patients had an ischaemic stroke or a heart attack. One patient reported prolonged neurological symptoms, related to a single dose of rizatriptan, but there were no pathological findings in several MRI-scans. Triptans seem to be safe and effective treatment for most hemiplegic migraine patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Hemorrhagic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Angle Closure Glaucoma: Treatment
Hemorrhagic Stroke ll: Pathophysiology

